首页|期刊导航|Nano Biomedicine & Engineering|Emerging Strategies in Smart Nano-PROTAC for Stimuli-Responsive Protein Degradation and Precision Cancer Therapy

Emerging Strategies in Smart Nano-PROTAC for Stimuli-Responsive Protein Degradation and Precision Cancer Therapy

Zhimin Weng Jiaojiao Yu Yuanrong Liao Yuanyuan Zhang Changmai Chen Wei Chen

Nano Biomedicine & Engineering2025，Vol.17Issue(3)：P.315-332,18.

Nano Biomedicine & Engineering2025，Vol.17Issue(3)：P.315-332,18.DOI:10.26599/NBE.2025.9290128

Emerging Strategies in Smart Nano-PROTAC for Stimuli-Responsive Protein Degradation and Precision Cancer Therapy

Zhimin Weng ¹Jiaojiao Yu ¹Yuanrong Liao ¹Yuanyuan Zhang ²Changmai Chen ¹Wei Chen¹

作者信息

1. Fujian Key Laboratory of Drug Target Discovery and Structural and Functional Research,School of Pharmacy,Fujian Medical University,Fuzhou 350122,China
2. ClinChoice Enterprise Management Co.,Ltd.,Shanghai 200032,China
折叠

摘要

关键词

proteolysis-targeting chimera(PROTAC)/nano-PROTAC/stimulus-responsive/precision cancer therapy/smart drug delivery system

分类

医药卫生

引用本文复制引用

Zhimin Weng,Jiaojiao Yu,Yuanrong Liao,Yuanyuan Zhang,Changmai Chen,Wei Chen..Emerging Strategies in Smart Nano-PROTAC for Stimuli-Responsive Protein Degradation and Precision Cancer Therapy[J].Nano Biomedicine & Engineering,2025,17(3):P.315-332,18.

基金项目

supported by grants from the National Natural Science Foundation of China(Grant No.22207017) （Grant No.22207017）

Fujian Province Natural Science Foundation(Grant No.2024J01501),and Joint Funds for the Innovation of Science and Technology of Fujian Province(Grant No.2024Y9099) （Grant No.2024J01501）

the Startup Fund for Scientific Research of Fujian Medical University(Grant No.2024QH2012)。（Grant No.2024QH2012）

Nano Biomedicine & Engineering

ISSN：2097-3837

访问量0

下载量0

段落导航